We are live on ! Find out more

Mid Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
RGC icon
126
Regencell Bioscience
RGC
$2.45B
$2.45B $4.94 3.7%
MD icon
127
Pediatrix Medical
MD
$2.45B
$2.45B $31.30 0.32%
NAMS icon
128
NewAmsterdam Pharma
NAMS
$2.42B
$2.42B $20.14 0.85%
UFPT icon
129
UFP Technologies
UFPT
$2.36B
$2.36B $305.06 0.28%
BEAM icon
130
Beam Therapeutics
BEAM
$2.36B
$2.36B $22.83 4.99%
PHVS icon
131
Pharvaris
PHVS
$2.36B
$2.36B $33.36 1.39%
ADUS icon
132
Addus HomeCare
ADUS
$2.29B
$2.29B $123 0.58%
CLDX icon
133
Celldex Therapeutics
CLDX
$2.26B
$2.26B $28.83 1.05%
PRGO icon
134
Perrigo
PRGO
$2.25B
$2.25B $16.24 0.37%
LKFT icon
135
Lakefront Biotherapeutics American Depositary Shares
LKFT
$2.24B
$2.24B $33.98 0.15%
PVLA icon
136
Palvella Therapeutics
PVLA
$2.23B
$2.23B $152.48 0.46%
SDGR icon
137
Schrodinger
SDGR
$2.22B
$2.22B $29.53 4.28%
IMNM icon
138
Immunome
IMNM
$2.22B
$2.22B $18.77 0.37%
BKD icon
139
Brookdale Senior Living
BKD
$2.19B
$2.19B $9.17 2.34%
PBH icon
140
Prestige Consumer Healthcare
PBH
$2.19B
$2.19B $46.19 1.92%
ALMR icon
141
Alamar Biosciences
ALMR
$2.14B
$2.14B $30.81 2.99%
ESTA icon
142
Establishment Labs
ESTA
$2.11B
$2.11B $70.75 3.1%
AUPH icon
143
Aurinia Pharmaceuticals
AUPH
$2.11B
$2.11B $15.73 2.96%
BHVN icon
144
Biohaven
BHVN
$2.09B
$2.09B $13.82 1.78%
REPL icon
145
Replimune Group
REPL
$2.08B
$2.08B $21.89 0.41%
NEO icon
146
NeoGenomics
NEO
$2.07B
$2.07B $16.02 3.14%
VERA icon
147
Vera Therapeutics
VERA
$2.03B
$2.03B $28.10 3.24%
SEPN icon
148
Septerna Inc
SEPN
$2.03B
$2.03B $42.60 1.77%
2 3 4 5
6

Mid Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 148 mid cap Healthcare stocks — companies in the Healthcare sector with a market cap between $2B and $10B — worth a combined $707B.

The largest by market cap are Madrigal Pharmaceuticals (MDGL) at $9.9B, Spyre Therapeutics (SYRE) at $9.9B and Bio-Rad Laboratories Class A (BIO) at $9.9B.

Among institutional investors, Definium Therapeutics (DFTX) drew the most net new fund positions in Q2 2026: 149 funds opened new positions, taking total fund holders up 114 (46%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.